Thursday, September 28, 2017

US FDA News: Endovascular Graft Systems: Letter to Health Care Providers - Type III Endoleaks Associated with Use

Type III endoleak may require treatment with additional interventions such as re-lining, insertion of additional endograft components, or open surgical repair. Interventions to address endoleaks carry added risks for impacted patients.
Read more: Endovascular Graft Systems: Letter to Health Care Providers - Type III Endoleaks Associated with Use